Previously, Pat was CEO, President and Director of Luminex Corporation, a publicly-traded diagnostics, tools and devices company. During his ten year tenure as CEO, Luminex increased sales more than eight-fold, transitioned from a loss position to segment-leading levels of profitability, made several strategic acquisitions and introduced numerous new products.
Prior to Luminex, Balthrop was President of Fisher Healthcare from 2002 to 2004. He also had a 20 year career at Abbott from 1981 to 2002, where he ran the company’s worldwide commercial operation, was the first head of Abbott Vascular, ran several R&D programs and was GM of the Far East Area, among other accomplishments.
In addition to his board position at Personalis, Balthrop is a director of Oxford Immunotec Global, a high growth diagnostics company focused on the development and commercialization of proprietary diagnostic tests for the management of immune-related conditions. Balthrop is also a director of NextGxDx, a private healthcare informatics company that is harnessing the power of the clinical value of the human genome.
Balthrop has an MBA from the Kellogg School of management at Northwestern University, and a BS in Biology from Spring Hill College.